A Polyplatin with Hands‐Holding Near‐Infrared‐II Fluorophores and Prodrugs at a Precise Ratio for Tracking Drug Fate with Realtime Readout and Treatment Feedback
- 11 May 2024
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 36 (30) , e2402452
Abstract
The in vivo fate of chemotherapeutic drugs plays a vital role in understanding the therapeutic outcome, side effects, and the mechanism. However, the lack of imaging abilities of drugs, tedious labeling processes, and premature leakage of imaging agents result in loss of fidelity between the drugs and imaging signals. Herein, an amphiphilic polymer is created by copolymerization of a near‐infrared‐II (NIR‐II) fluorophore tracer (T) and an anticancer Pt(IV) prodrug (D) of cisplatin in a hand‐holding manner into one polymer chain for the first time. The obtained PolyplatinDT is capable of delivering the drugs and the fluorophores concomitantly at a precise D/T ratio, thereby resulting in tracking the platinum drugs and even readout of them in real‐time via NIR‐II imaging. PolyplatinDT can self‐assemble into nanoparticles, referred to as NanoplatinDT. Furthermore, a caspase‐3 cleavable peptide that serves as an apoptosis reporter is attached to NanoplatinDT, resulting in NanoplatinDTR that are capable of simultaneously tracking platinum drugs and evaluating the therapeutic efficacy. Overall, it is reported here the design of the first theranostic polymer with anticancer drugs, drug tracers, and drug efficacy reporters that can work in concert to provide insight into the drug fate and mechanism of action.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC2507000)
- National Natural Science Foundation of China (22175189, 52373127)
- Fundamental Research Funds for the Central Universities (buctrc202220)
This publication has 61 references indexed in Scilit:
- Alendronate Triggered Dual‐Cascade Targeting Prodrug Nanoparticles for Enhanced Tumor Penetration and STING Activation of OsteosarcomaAdvanced Functional Materials, 2023
- Unraveling and Overcoming Platinum Drug‐Resistant Cancer Tumors with DNA NanostructuresAdvanced Functional Materials, 2022
- Reduction Sensitive Polymers Delivering Cationic Platinum Drugs as STING Agonists for Enhanced Chemo‐ImmunotherapyAdvanced Functional Materials, 2022
- Bio‐Conjugated Advanced Materials for Targeted Disease TheranosticsAdvanced Functional Materials, 2020
- Real‐Time Quantification of Cell Internalization Kinetics by Functionalized Bioluminescent NanoprobesAdvanced Materials, 2019
- 2D Nanomaterials for Cancer Theranostic ApplicationsAdvanced Materials, 2019
- Recent Advances of Optical Imaging in the Second Near‐Infrared WindowAdvanced Materials, 2018
- Advances in Biomaterials for Drug DeliveryAdvanced Materials, 2018
- Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)–Green Tea Catechin Conjugate for Cancer TherapyAdvanced Materials, 2018
- Emerging Nanotechnology and Advanced Materials for Cancer Radiation TherapyAdvanced Materials, 2017